Development of a Computerized Adverse Drug Event (ADE) Monitor in the Outpatient Setting

摘要

This paper describes the collaboration of Brigham and Women's Hospital and Regenstrief Institute to develop a computerized adverse drug event (ADE) monitor using electronic medical records from outpatient practices. We describe the steps involved in ADE monitor development and rule validation at large outpatient practices at Boston and Indianapolis. The final standard rule set adopted by both practice sites are currently being used to test the impact of basic and advanced decision support on ADE rates.